2026 Q2 Portfolio Activity
In 2026 Q2, Ishara Investments LP maintained a portfolio of 53 distinct positions. The most significant new addition was AGIOS PHARMACEUTICALS INC, now representing 4.47% of the total fund value. They heavily accumulated shares in ACADIA PHARMACEUTICALS INC, increasing the position by 233.3%. Conversely, Ishara Investments LP completely exited their position in KALVISTA PHARMACEUTICALS INC.
Position History
hover any row below to update
Loading…
Ishara Investments LP
AUM $136M
Total Positions
53
Quarter
2026 Q2
Top Holding
ACAD (7.6%)
Top 10 Concentration
51.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 53
Ishara Investments LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 7.62% | 2.59% |
#1
16
Prev: #17
|
8.0 |
—
|
287,000 | 233.3% |
P
S
|
410,000 | $10,373,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XERS
XERIS BIOPHARMA...
|
Healthcare | 7.16% | 5.63% |
#2
2
Prev: #4
|
6.9 |
—
|
205,000 | 20.0% |
P
S
|
1,230,000 | $9,741,600 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 6.03% | 4.39% |
#3
4
Prev: #7
|
6.4 |
—
|
61,500 | 75.0% |
P
S
|
143,500 | $8,211,070 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 5.55% | 6.88% |
#4
3
Prev: #1
|
3.7 |
—
|
no change | no change |
P
S
|
22,550 | $7,549,515 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 5.03% | 3.46% |
#5
4
Prev: #9
|
4.5 |
—
|
30,750 | 17.6% |
P
S
|
205,000 | $6,844,950 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 4.47% | — |
#6
Prev: #—
|
5.3 |
—
|
164,000 | — |
NEW
|
164,000 | $6,086,040 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 4.01% | — |
#7
Prev: #—
|
5.1 |
—
|
51,250 | — |
NEW
|
51,250 | $5,464,275 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 3.95% | — |
#8
Prev: #—
|
5.1 |
—
|
143,500 | — |
NEW
|
143,500 | $5,369,770 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 3.65% | 2.72% |
#9
6
Prev: #15
|
2.0 |
—
|
-205,000 | -16.7% |
P
S
|
1,025,000 | $4,971,250 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 3.50% | 3.16% |
#10
1
Prev: #11
|
3.9 |
—
|
24,600 | 42.9% |
P
S
|
82,000 | $4,766,660 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 3.44% | 0.91% |
#11
22
Prev: #33
|
4.4 |
—
|
645,750 | 370.6% |
P
S
|
820,000 | $4,682,200 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 3.42% | 3.11% |
#12
1
Prev: #13
|
1.4 |
—
|
-28,700 | -25.9% |
P
S
|
82,000 | $4,658,420 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNXP
TONIX PHARMACEU...
|
Healthcare | 3.17% | — |
#13
Prev: #—
|
4.8 |
—
|
338,250 | — |
NEW
|
338,250 | $4,316,070 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 3.14% | — |
#14
Prev: #—
|
4.8 |
—
|
57,400 | — |
NEW
|
57,400 | $4,275,152 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 2.95% | 6.56% |
#15
13
Prev: #2
|
1.2 |
—
|
-24,600 | -60.0% |
P
S
|
16,400 | $4,014,228 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 2.47% | 1.76% |
#16
8
Prev: #24
|
3.5 |
—
|
63,000 | 44.4% |
P
S
|
205,000 | $3,359,950 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LXRX
LEXICON PHARMAC...
|
Healthcare | 2.24% | 1.33% |
#17
12
Prev: #29
|
3.4 |
—
|
369,000 | 40.9% |
P
S
|
1,271,000 | $3,050,400 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 2.23% | — |
#18
Prev: #—
|
4.4 |
—
|
276,750 | — |
NEW
|
276,750 | $3,035,948 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 2.22% | 2.03% |
#19
2
Prev: #21
|
3.9 |
—
|
82,000 | 80.0% |
P
S
|
184,500 | $3,025,800 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GMAB
GENMAB A/S
|
Healthcare | 2.07% | 2.08% |
#20
Prev: #20
|
3.3 |
—
|
20,500 | 25.0% |
P
S
|
102,500 | $2,815,675 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 2.05% | — |
#21
Prev: #—
|
4.3 |
—
|
32,800 | — |
NEW
|
32,800 | $2,794,232 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 2.03% | 2.10% |
#22
3
Prev: #19
|
3.3 |
—
|
20,500 | 25.0% |
P
S
|
102,500 | $2,765,450 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 1.79% | 0.70% |
#23
12
Prev: #35
|
0.7 |
—
|
-85,150 | -60.6% |
P
S
|
55,350 | $2,434,847 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 1.54% | — |
#24
Prev: #—
|
4.1 |
—
|
369,000 | — |
NEW
|
369,000 | $2,095,920 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 1.40% | — |
#25
Prev: #—
|
4.1 |
—
|
328,000 | — |
NEW
|
328,000 | $1,905,680 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 1.37% | — |
#26
Prev: #—
|
4.0 |
—
|
26,650 | — |
NEW
|
26,650 | $1,860,437 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 1.24% | 2.67% |
#27
11
Prev: #16
|
0.5 |
—
|
-26,650 | -46.4% |
P
S
|
30,750 | $1,691,250 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 1.22% | — |
#28
Prev: #—
|
4.0 |
—
|
32,800 | — |
NEW
|
32,800 | $1,664,600 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 1.13% | 1.61% |
#29
4
Prev: #25
|
1.5 |
—
|
no change | no change |
P
S
|
5,125 | $1,542,779 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 1.03% | 1.29% |
#30
Prev: #30
|
0.4 |
—
|
-16,400 | -28.6% |
P
S
|
41,000 | $1,407,120 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.99% | 1.87% |
#31
8
Prev: #23
|
3.4 |
—
|
73,800 | 150.0% |
P
S
|
123,000 | $1,350,540 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.98% | 1.23% |
#32
1
Prev: #31
|
2.9 |
—
|
20,500 | 20.0% |
P
S
|
123,000 | $1,332,090 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 0.92% | 1.12% |
#33
1
Prev: #32
|
1.4 |
—
|
no change | no change |
P
S
|
36,900 | $1,250,541 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 0.90% | — |
#34
Prev: #—
|
3.9 |
—
|
2,460 | — |
NEW
|
2,460 | $1,221,956 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SPRY
ARS PHARMACEUTI...
|
Healthcare | 0.84% | — |
#35
Prev: #—
|
3.8 |
—
|
143,490 | — |
NEW
|
143,490 | $1,149,355 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MNPR
MONOPAR THERAPE...
|
Healthcare | 0.84% | — |
#36
Prev: #—
|
3.8 |
—
|
12,300 | — |
NEW
|
12,300 | $1,138,857 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ERAS
ERASCA INC
|
Healthcare | 0.55% | — |
#37
Prev: #—
|
3.7 |
—
|
41,000 | — |
NEW
|
41,000 | $751,120 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 0.32% | 3.12% |
#38
26
Prev: #12
|
0.1 |
—
|
-71,750 | -87.5% |
P
S
|
10,250 | $439,828 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 0.23% | 1.43% |
#39
11
Prev: #28
|
0.1 |
—
|
-123,000 | -80.0% |
P
S
|
30,750 | $311,498 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MREO
MEREO BIOPHARMA...
|
Healthcare | 0.18% | — |
#40
Prev: #—
|
3.6 |
—
|
768,750 | — |
NEW
|
768,750 | $244,232 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GOSS
GOSSAMER BIO IN...
|
Healthcare | 0.10% | 0.26% |
#41
4
Prev: #37
|
1.0 |
—
|
no change | no change |
P
S
|
820,000 | $134,972 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 0.00% | 0.66% |
Sold All 😨
(Was: #36) |
0.0 |
—
|
-10,250 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 0.00% | 0.78% |
Sold All 😨
(Was: #34) |
0.0 |
—
|
-24,600 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 0.00% | 1.47% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-49,200 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LGND
LIGAND PHARMACE...
|
Healthcare | 0.00% | 1.55% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-8,200 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CPRX
CATALYST PHARMA...
|
Healthcare | 0.00% | 1.92% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-82,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.00% | 2.56% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-451,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.00% | 3.08% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-174,250 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 0.00% | 3.29% |
Sold All 😨
(Was: #10) |
0.0 |
—
|
-55,350 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 0.00% | 4.11% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-820,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 53 holdings